Kiora Pharmaceuticals (KPRX) executive compensation, 2026 proxy

Brian M. Strem, Ph.D, President and Chief Executive Officer, was paid $971,696 in 2025, up 2% from $954,883 the year before.

Filed
April 30, 2026
Annual meeting
June 10, 2026
Pay year
2025
Named executives
3
CEO total pay
$971,696+2% vs prior year
CEO pay in equity
14%$132,297 in awards
Strem bonus target
55%Effective July 1, 2024
Daniels total compensation
$957,5042025 total
Tosca total compensation
$516,7332025 total
Daniels all-other compensation
$295,446Includes relocation compensation
Tosca bonus target
40%Of annual base salary
Daniels bonus target
40%Of annual base salary

How Ph.D was paid

$971,696 in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary60%Bonus26%Stock awards5%Option awards9%All other compensation0%

Named executive officers

ExecutiveTotal
Brian M. Strem, Ph.DPresident and Chief Executive Officer$971,696
Eric J. Daniels, MD, MBAFormer Chief Development Officer$957,504
Melissa ToscaChief Financial Officer$516,733

What changed and why

  • $972K$971,696 was CEO Brian Strem’s 2025 total compensation, up from $954,883 in 2024.
  • $254K$254,224 was Strem’s 2025 discretionary bonus, compared with $268,787 in 2024.
  • $46,707$46,707 in stock awards and $85,590 in option awards were granted to Strem in 2025.
  • 55%CEO bonus target increased to 55% of annual base salary effective July 1, 2024.
  • $295K$295,446 was Eric Daniels’s 2025 all-other compensation, including relocation compensation.
  • Performance bonuses and equity awards formed the principal variable compensation components for named executives.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.